Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,293 papers from all fields of science
Search
Sign In
Create Free Account
Suppressor effector T lymphocyte
Known as:
Suppressor-Effector T-Lymphocyte
, Suppressor T Lymphocyte
, Suppressor-Effector T-Lymphocytes
Expand
Subpopulation of CD8+ T-lymphocytes which suppress antibody production or inhibit cellular immune responses. Suppressor-effector cells execute the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
CD4+ CD25+ Regulatory T Cells
Hematopoietic and Lymphoid Tissue
Lymphoid Tissue
Broader (1)
Suppressor T Lymphocyte
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The I-J-disparate mouse strains B10.A(3R) and B10.A(5R) have identical Eβ sequences
J. Gorski
,
C. Hayes
Immunogenetics
2004
Corpus ID: 8960096
In the mouse, one of the most useful T suppressor cell (Ts) markers is I-J (Murphy 1987). However, the difficulty in…
Expand
1993
1993
Murine CD8+ T suppressors against mycobacterial 65‐kDa antigen compete for IL‐2 and show lack of major histocompatibility complex‐imposed restriction specificity in antigen recognition
Smita Khetan
,
K. Sainis
,
S. Rath
,
R. Kamat
European Journal of Immunology
1993
Corpus ID: 41730151
The mechanism of antigen‐specific suppression and reasons for aberrant major histocompatibility complex (MHC) class II…
Expand
1984
1984
Analysis of hapten-specific T suppressor factors: genetic restriction of TsF1 activity analyzed with synthetic hybrid suppressor molecules.
A. Lowy
,
P. Flood
,
+4 authors
M. Greene
Journal of Immunology
1984
Corpus ID: 44715745
We have analyzed the first-order suppressor factor secreted by an azobenzenearsonate (ABA)-specific T suppressor cell (Ts…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE